| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.9M | -3.7% |
| Cost of Revenue | $3.1M | +4.6% |
| R&D Expense | $9K | -83.0% |
| SG&A Expense | $7.0M | -27.4% |
| Operating Income | -$2.5M | +31.5% |
| Pre-tax Income | -$2.3M | +45.9% |
| Income Tax | $8K | +0.0% |
| Net Income | -$2.3M | +66.8% |
| EPS (Basic) | -$1.71 | +66.9% |
| EPS (Diluted) | -$1.71 | +66.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $259K | -93.9% |
| Short-term Investments | $4.3M | — |
| Accounts Receivable | $425K | -63.8% |
| Inventory | $1.2M | +34.1% |
| Current Assets | $6.4M | -31.2% |
| Total Assets | $6.5M | -51.6% |
| Current Liabilities | $2.1M | -19.7% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.7M | +50.8% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $750K | -89.8% |
| Financing Cash Flow | $6K | -33.3% |
| Free Cash Flow | -$4.7M | +50.9% |
| $2.4M |
| -67.0% |
| Stockholders' Equity | $4.1M | -33.5% |